BWAY News and Press, BrainsWay Ltd. From 11/27/23

BrainsWay Ltd. (NASDAQ: BWAY) is the focus of IBN's latest stock spotlight. The company's shares have moved 3.64% on the day to $3.27. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally...

BrainsWay Ltd. (NASDAQ: BWAY) is the focus of IBN's latest stock spotlight. The company's shares have moved 3.64% on the day to $3.27. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally...

BURLINGTON, Mass. and JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Blue Cross ...

2023-11-20 00:01:19 ET Summary BrainsWay reported solid results in Q3 2023 and is now on the verge of sustainable profitability. BrainsWay's focus on larger organizations appears to be supporting growth and improving sales efficiency. While BrainsWay's share price has increase...

2023-11-15 14:52:05 ET Brainsway Ltd (BWAY) Q3 2023 Earnings Conference Call November 15, 2023, 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Con...

2023-11-15 07:33:31 ET More on Brainsway Seeking Alpha’s Quant Rating on Brainsway Historical earnings data for Brainsway Financial information for Brainsway For further details see: Brainsway GAAP EPS of -$0.01 beats by $0.03, revenue of $8.3M bea...

Generated Robust 61% Year-over-Year Revenue Growth in Q3 2023 Nearing Breakeven Operating Income, Achieved Positive Adjusted EBITDA, with Cash Flow from Operations Exceeding $1 Million Conference Call to be Held Today at 8:30 AM EST BURLINGTON, Mass. and JERUSALEM, Nov. 15...

The RMR Group Inc. (RMR) is expected to report $0.46 for Q4 2023 Indra Sistemas ADR (ISMAY) is expected to report for Q3 2023 Ceapro Inc. (CRPOF) is expected to report for Q2 2024 Tuya Inc. American Depositary Shares each representing one Class A (TUYA) is expected to report $-0.02 fo...

BrainsWay Ltd. (BWAY) is expected to report $-0.07 for Q3 2023

BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced today that the Clinica...